menu search

Here's why cognex stock crashed in october

Consumer electronics, logistics, and automotive spending plans have been held back in 2023. The company's tech...

November 4, 2023, 10:58 am

Biden's ai executive order: it's about understanding this technology, the risks, says c3.ai ceo

President Biden signed into action a sweeping executive order to promote innovation in artificial intelligence while also seeking to enforce effective...

November 4, 2023, 9:00 am

Micron is positioned to enjoy the semiconductors next cycle

Micron is an attractive investment opportunity in the information technology sector, operating in the g...

November 4, 2023, 1:39 am

10x genomics: unveiling the investment potential

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Ge...

November 4, 2023, 1:02 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Bectran to sponsor credit research foundation’s november forum as a platinum partner

CHICAGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bectran, Inc., the industry leader in innovative, cutting-edge tec...

November 3, 2023, 9:31 pm

Clearstar announces appointment of mike pritts as chief executive officer

New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and ...

November 3, 2023, 8:50 pm

Gd culture group limited announces closing of $10 million registered direct offering priced at-the-market under nasdaq rules

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), a holding company currently cond...

November 3, 2023, 8:05 pm

Why gartner stock popped today

Gartner beat expectations on revenue, earnings and free cash flow in the third quarter. The technology ...

November 3, 2023, 4:57 pm

Board of gm's cruise reviewing regulatory response, technology

The board of Cruise, the robo-taxi company controlled by General Motors , has hired an outside law firm and te...

November 3, 2023, 4:39 pm

Yelp seeing its best quarter, cfo says

Yelp CFO David Schwarzbach joins Caroline Hyde and Ed Ludlow to discuss their quarterly results and why he believes the company's product-led strategy...

November 3, 2023, 4:23 pm

Ice's october report: a 15% surge in total adv and radiance of the energy sector

Intercontinental Exchange, Inc. (NYSE: ICE), a data, technology, and market infrastructure firm, revealed trading statistics for October 2023. ICE's O...

November 3, 2023, 4:08 pm

Intesa sanpaolo s.p.a. (isnpy) q3 2023 earnings call transcript

Intesa Sanpaolo S.p.A. (OTCPK:ISNPY) Q3 2023 Results Conference Call November 3, 2023 10:00 AM ET Company Participants Carlo Messina - Chief Executive...

November 3, 2023, 2:50 pm

Fintech’s role in financial guidance

Financial guidance and advisory services are undergoing a transition in an increasingly digital world, fueled by the rise of fintech firms. Fintech, o...

November 3, 2023, 12:51 pm

Workhorse group reschedules third quarter 2023 earnings call to tuesday, november 14, 2023 at 8:00 a.m. et

CINCINNATI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American ...

November 3, 2023, 12:30 pm

Longeveron to report third quarter 2023 results and provide corporate update on november 10, 2023

MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage bio...

November 3, 2023, 12:00 pm

It consultant gartner's stock rockets to a record as uncertainty and volatility fuel big earnings beat

Shares of Gartner Inc. blasted off into record territory Friday after the information-technology resear...

November 3, 2023, 11:39 am


Search within

Pages Search Results: